EXCLUSIVE: GT Biopharma Advances Relapsed Blood Cancer Therapy Trial To Cohort 2 After Promising Early Safety Results – GT Biopharma (NASDAQ:GTBP)
GT Biopharma, Inc. GTBP announced Monday that it has successfully completed dosing in Cohort 1 and started dosing…